Fidelity Investments
INSY

Fidelity Investments’s Insys Therapeutics, Inc. INSY Stock Holding History

Fidelity Investments’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-242,764
Closed -$1.47M – 2773
2018
Q1 		$1.47M Buy
242,764
+69,080
+40% +$570K ﹤0.01% 2397
2017
Q4 		$1.67M Sell
173,684
-53,400
-24% -$349K ﹤0.01% 2379
2017
Q3 		$2.02M Sell
227,084
-27,504
-11% -$284K ﹤0.01% 2326
2017
Q2 		$3.22M Buy
254,588
+11,504
+5% +$136K ﹤0.01% 2257
2017
Q1 		$2.56M Sell
243,084
-13,661
-5% -$146K ﹤0.01% 2320
2016
Q4 		$2.36M Sell
256,745
-466,010
-64% -$5.26M ﹤0.01% 2350
2016
Q3 		$8.52M Sell
722,755
-71,890
-9% -$1.09M ﹤0.01% 2042
2016
Q2 		$10.3M Sell
794,645
-436,439
-35% -$6.36M ﹤0.01% 1949
2016
Q1 		$19.7M Sell
1,231,084
-1,235,900
-50% -$23.5M ﹤0.01% 1671
2015
Q4 		$70.6M Hold
2,466,984
– – 0.01% 1117
2015
Q3 		$70.2M Buy
2,466,984
+10,000
+0.4% +$368K 0.01% 1103
2015
Q2 		$88.3M Hold
2,456,984
– – 0.01% 1092
2015
Q1 		$71.4M Buy
2,456,984
+377,444
+18% +$9.98M 0.01% 1184
2014
Q4 		$43.8M Buy
2,079,540
+7,200
+0.3% +$142K 0.01% 1388
2014
Q3 		$40.2M Hold
2,072,340
– – 0.01% 1402
2014
Q2 		$32.4M Sell
2,072,340
-167,000
-7% -$2.7M ﹤0.01% 1567
2014
Q1 		$46.4M Buy
2,239,340
+2,139,041
+2,133% +$42.4M 0.01% 1362
2013
Q4 		$1.29M Buy
+100,299
New +$1.39M ﹤0.01% 2415

Other funds holding INSY

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Fidelity Investments's INSY Position: Q2 2018 in Review

Fidelity Investments sold out of Insys Therapeutics, Inc. (INSY) in Q2 2018, closing a stake of 242,764 shares — an estimated $1.47M sold.

Fidelity Investments first reported a position in INSY in Q4 2013 and held it in 18 quarters. The position peaked at $88.3M in Q2 2015. 103 funds tracked by Wall St. Rank hold INSY as of Q2 2018.

  • Fidelity Investments reported no remaining Insys Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
  • Fidelity Investments sold 242,764 Insys Therapeutics, Inc. shares in Q2 2018, an estimated $1.47M.
  • Fidelity Investments first reported a position in Insys Therapeutics, Inc. in Q4 2013 and held it in 18 quarters.
  • Fidelity Investments's Insys Therapeutics, Inc. position peaked at $88.3M in Q2 2015.
  • 103 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2018.

Based on Fidelity Investments's 13F filing for Q2 2018, filed 10 Aug 2018.